Udisha Srivastav &Amp;Amp; Ruchika Chitravanshi

Stories by Udisha Srivastav &Amp;Amp; Ruchika Chitravanshi

How the new Companies Act will affect Tata Sons, Bharti Telecom

How the new Companies Act will affect Tata Sons, Bharti Telecom

Rediff.com   22 Feb 2021

Companies such as Tata Sons and Bharti Telecom, which are unlisted but have listed subsidiaries, may soon have to file periodic financial statements with the registrar of companies under the new provision of the Companies Act. The provision requires greater financial disclosures by a certain category of unlisted companies.

After a year of Covid, India may not face a second wave

After a year of Covid, India may not face a second wave

Rediff.com   9 Feb 2021

Epidemiologists point out that if there is no second wave, it means that the number of infected has surpassed the uninfected, reports Ruchika Chitravanshi.

Despite Covid, registration of new companies went up in 2020

Despite Covid, registration of new companies went up in 2020

Rediff.com   24 Jan 2021

Moreover, 5,611 companies struck off earlier by the ministry of corporate affairs because of compliance-related lacunae, were registered again.

Trusts, societies have to register with MCA by April 1

Trusts, societies have to register with MCA by April 1

Rediff.com   23 Jan 2021

Corporate social responsibility rules that kicked in on Friday also set a three year time-limit for any CSR project, among a series of other amendments introduced by the government.

Covaxin has tolerable safety: Lancet

Covaxin has tolerable safety: Lancet

Rediff.com   23 Jan 2021

The vaccine was well tolerated in all dose groups with no vaccine-related adverse events.

Budget 2021: Sharper focus on health care likely

Budget 2021: Sharper focus on health care likely

Rediff.com   20 Jan 2021

CII has also called for tax incentives for new health care projects and import duty relief for lifesaving equipment.

Govt proposes phase-wise pre-packed insolvency process

Govt proposes phase-wise pre-packed insolvency process

Rediff.com   18 Jan 2021

A draft proposal by the sub-committee of the insolvency law committee has recommended that the corporate debtor (CD) may initiate the prepack since it may prove difficult to implement if creditors are allowed to do so without the willingness of the promoter.

'Vaccine is far safer than getting Covid'

'Vaccine is far safer than getting Covid'

Rediff.com   16 Jan 2021

'I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment since at least 11,500 have got at least one dose by now and it has proven to be safe.'

COVID-19 Vaccine: Vial, syringe makers ramp up

COVID-19 Vaccine: Vial, syringe makers ramp up

Rediff.com   2 Jan 2021

'The government should put the whole road map together for the vaccine and decide how industry can support...' 'They should allow the private sector to vaccinate.'

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com   31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Nod for Covid vaccine in next few days: Serum Institute's Poonawalla

Rediff.com   29 Dec 2020

The Serum Institute of India has stockpiled 40 mn-50 mn doses and is adding more every week. Most of these will come to India.

'Unprecedented vaccine trial in India'

'Unprecedented vaccine trial in India'

Rediff.com   23 Dec 2020

Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.

COVID-19: How to get vaccinated

COVID-19: How to get vaccinated

Rediff.com   19 Dec 2020

For vaccination, online registration is mandatory. Thereafter, eligible beneficiaries will be informed on their registered mobile number about the nearest vaccination facility, and the date and time of vaccination.

More than 60% of bankruptcy proceedings led to liquidation in Q2

More than 60% of bankruptcy proceedings led to liquidation in Q2

Rediff.com   16 Dec 2020

Experts say this further underlines the lack of investor interest in stressed assets at present.

Covid: How Pfizer plans to resolve cold storage issues in India

Covid: How Pfizer plans to resolve cold storage issues in India

Rediff.com   7 Dec 2020

The company has developed detailed logistical plans and tools to support effective vaccine transport, storage, and temperature monitoring. Sohini Das and Ruchika Chitravanshi report.

Govt to decriminalise provisions of LLP Act

Govt to decriminalise provisions of LLP Act

Rediff.com   23 Nov 2020

One of the changes being proposed is allowing LLPs to issue non-convertible debentures.

Foreign listing of start-ups, MSMEs will now be easier

Foreign listing of start-ups, MSMEs will now be easier

Rediff.com   10 Nov 2020

The criteria for allowing companies to avail of this provision will include profitability, networth, paid-up capital, and turnover.

Festive delight for employees as firms begin to roll back salary cuts

Festive delight for employees as firms begin to roll back salary cuts

Rediff.com   30 Oct 2020

HR experts estimate that up to 70 per cent companies in the manufacturing and services space including sectors like auto components, edutech and construction equipment are looking to restore the salary cuts over the next couple of months.

How complex is the process of getting approval for a vaccine?

How complex is the process of getting approval for a vaccine?

Rediff.com   30 Sep 2020

Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through this carefully drawn journey of vaccine development.

FCRA challenge for foreign think tanks in India

FCRA challenge for foreign think tanks in India

Rediff.com   28 Sep 2020

Funding challenges are not limited to just one think tank. Several scholars say that access for conducting research and getting foreign funds has become a major hurdle for think tanks, with the government raising many questions regarding such inflows. As a result, many think tanks are keeping a low profile and becoming less prolific.